Human Parvovirus 4 Infection, Cameroon

In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavoie, Myriam, Sharp, Colin P., Pépin, Jacques, Pennington, Christopher, Foupouapouognigni, Yacouba, Pybus, Oliver G., Njouom, Richard, Simmonds, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2012
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309673/
https://www.ncbi.nlm.nih.gov/pubmed/22469425
http://dx.doi.org/10.3201/eid1804.110628
Descripción
Sumario:In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C virus seropositivity. Findings suggest parenteral acquisition of some PARV4 infections.

Ejemplares similares